Dose Optimization using the Gene Therapy Virtual Twin® Platform
Read how using the Gene Therapy Virtual Twin Platform can help optimize dosing for patients
与 QSP 专家建立联系
联系 Certara,探讨 QSP 服务如何加速您的药物研发项目我们的专家团队随时准备为您提供定制化解决方案。
Home / On-Demand Webinar / Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients – Japanese subtitles
Healthcare is moving beyond the “one-size-fits-all” model. Precision medicine focuses on delivering the right treatment at the right time to the right patient. A key part of this evolution is precision dosing—optimizing medication to maximize effectiveness and reduce side effects.
In this webinar, Dr. Tom Polasek from Certara demonstrates how Virtual Twin technology and PBPK (physiologically based pharmacokinetic) modeling can simulate real patient characteristics to predict optimal drug dosing using the Simcyp® Simulator.
Learn how model-informed precision dosing (MIPD) and Virtual Twin® simulations are transforming personalized healthcare and clinical decision-making.
Read how using the Gene Therapy Virtual Twin Platform can help optimize dosing for patients
联系 Certara,探讨 QSP 服务如何加速您的药物研发项目我们的专家团队随时准备为您提供定制化解决方案。
